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Open access under CC BYProposal and execution of clinical trials, computation of quality measures and discovery of correlation
between medical phenomena are all applications where an accurate count of patients is needed. How-
ever, existing sources of this type of patient information, including Clinical Data Warehouses (CDWs)
may be incomplete or inaccurate. This research explores applying probabilistic techniques, supported
by the MayBMS probabilistic database, to obtain accurate patient counts from a Clinical Data Warehouse
containing synthetic patient data.
We present a synthetic Clinical Data Warehouse, and populate it with simulated data using a custom
patient data generation engine. We then implement, evaluate and compare different techniques for
obtaining patients counts.
We model billing as a test for the presence of a condition. We compute billing’s sensitivity and spec-
iﬁcity both by conducting a ‘‘Simulated Expert Review’’ where a representative sample of records are
reviewed and labeled by experts, and by obtaining the ground truth for every record.
We compute the posterior probability of a patient having a condition through a ‘‘Bayesian Chain’’, using
Bayes’ Theorem to calculate the probability of a patient having a condition after each visit. The second
method is a ‘‘one-shot’’ approach that computes the probability of a patient having a condition based
on whether the patient is ever billed for the condition.
Our results demonstrate the utility of probabilistic approaches, which improve on the accuracy of raw
counts. In particular, the simulated review paired with a single application of Bayes’ Theorem produces
the best results, with an average error rate of 2.1% compared to 43.7% for the straightforward billing
counts.
Overall, this research demonstrates that Bayesian probabilistic approaches improve patient counts on
simulated patient populations. We believe that total patient counts based on billing data are one of the
many possible applications of our Bayesian framework. Use of these probabilistic techniques will enable
more accurate patient counts and better results for applications requiring this metric.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction 100% complete and accurate, performing these tasks would beData quality is critical to modern research and clinical practice.
Historically, ‘‘data quality’’ could refer simply to physicians having
legible handwriting. In this day and age, clinical data is extensively
used to compute quality measures, document physician perfor-
mance, determine payments for meaningful use, discover interest-
ing correlations between medical phenomena, and plan and
perform clinical research. If the structured information in Electronic
Health Records (EHRs) and Clinical Data Warehouses (CDWs) weres), Jorge.R.Herskovic@uth.tm
-NC-ND license. straightforward.
Unfortunately, structured information is not complete, nor is it
entirely accurate. One commonly used kind of structured informa-
tion is billing data. Billing data is incomplete because other consid-
erations beyond diagnosis go into invoicing. For example, it is
fraudulent to bill patients for conditions they have but a practi-
tioner does not treat. UTHealth’s physicians practice in clinics
and hospitals that are geographically close to UT MD Anderson
Cancer Center (MDACC). Many UTHealth patients with cancer get
their treatment at MDACC, which bills them for this service. These
patients’ invoices therefore (legally and appropriately) do not list
cancer as a diagnosis at UTHealth, rendering their condition invis-
ible to searches that rely on billing data.
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routinely classiﬁed by ICD-9-CM condition in order to bill insur-
ance companies or Medicare/Medicaid. Billing therefore became a
convenient, de facto registry of disease and is now commonly used
to ﬁnd patients with certain conditions. In other words, in practice
the question ‘‘which of our patients has breast cancer?’’ is often
turned into ‘‘Who have we billed for breast cancer?’’ In essence,
we are labeling the patient by assigning billing codes. Administra-
tive data has become more available due to the rise of the CDW.
CDWs collect data from clinical systems such as Electronic Health
Records and administrative databases and repurpose it for re-
search, reporting, and study planning [1,2]. Furthermore, EHRs
and CDWs provide the additional beneﬁts of providing large vol-
umes of longitudinal patient information that is relatively easy to
access [3].
As mentioned earlier, if the information in EHRs and CDWs is
complete and accurate, performing the aforementioned tasks will
be straightforward. However, patient labeling in electronic systems
can be inaccurate. For example, UTHealth does not bill approxi-
mately 50% of patients who have or have had breast cancer for
the condition. Further, 80% of patients with endometrial cancer
at some point in their lives have not been billed for any related
codes at UTHealth [4]. Related research has similar results: only
52% of patients with an ICD-9-CM code for Wegener’s Granuloma-
tosis at St. Alexius Medical Center actually met the diagnostic cri-
teria for the condition [5]. A strategy combining different ICD-9
codes yielded an 88% positive predictive value (PPV) for Lupus
Nephritis cases at Brigham & Women’s Hospital in Boston. The
authors do not mention how many cases their strategy misses,
and their experimental design makes it impossible to compute
how many are missed [6]. Many other studies show inaccuracies
when counting patients [7–12]. These database counts are also
used to draw conclusions; for example, the prevalence of myocar-
dial infarctions for patients on rosiglitazone may be higher than for
patients on other hypoglycemic medications [13]. Conversely, Hen-
nessy et al. conducted a validation study to determine the positive
predictive value (PPV) of the ﬁrst listed diagnosis code for sudden
cardiac death and ventricular arrhythmias. These researchers con-
ducted record reviews and conﬁrmed that the ﬁrst diagnosis codes
were highly predictive of these conditions [14]. Finally, Schnee-
weiss points out that data entered into EHRs is subject to physician
and organizational bias, where factors contributing to a diagnosis
and institutional practices regarding the number of diagnoses re-
ported can impact the data recorded. In particular, Schneeweiss
points out that ‘‘under-reporting of secondary diagnoses’’ is a
known and common issue [3].
Terris et al. discuss the sources of bias in data recording, includ-
ing the impact of physician assessment of impact of ﬁndings on a
patient’s primary presenting condition as well as the time and re-
sources available to record detailed data. As expected, data most
relevant to the primary condition were more likely to be recorded
than were data pertinent to secondary conditions [15].
Measuring the quality of data is further complicated by the dif-
ﬁculty of obtaining a ‘‘gold standard’’ for comparison. The common
approach is an expensive and time-consuming review by a profes-
sional coder. However, even this approach has been shown to be
inconsistent, with one study showing a consensus level of 86% with
the chief abstractor [16]. One well-controlled study introduced
random errors at predeﬁned rates into an existing database (which
was considered the gold standard in this case). The signiﬁcance of
the errors on the ﬁnal results, in particular with regard to low fre-
quency events, was substantial [17].
Measurement error can be divided into two types: noise, and
bias. Noise is the result of random ﬂuctuations in the measurement
process, recording, or retrieval. Bias is a systematic deviation of
measurement from the true state of the world [18,19]. The inaccu-racies in patient counts cited earlier are the result of bias. In
UTHealth’s example, they are largely due to the characteristics of
its clinical and administrative workﬂow. In other words, we believe
that in UTHealth’s case, they are a kind of bias [4]. This type of bias
is also described by Schneeweiss [3]. Our insight is that biases in
labeling can be measured and compensated. In this paper, we ex-
plore the use of probabilistic techniques to correct for biases in la-
beled data. We demonstrate our probabilistic approach on billing
information, a common source of aggregate data for study plan-
ning, reporting, and quality measures.
Organizations such as the Observational Medical Outcomes
Partnership (OMOP, http://omop.fnih.org) have focused on using
observational data, including claims and EHR data, to detect
drug-condition relationships. In addition, OMOP promotes the
use of simulated data based on probability distributions of actual
patient data. We follow a similar approach in our research. Actual
clinical ﬁndings can only be inferred when applying these methods
to actual clinical data.
As in the OMOP model, we chose to simulate the data ware-
house environment with synthesized data, complete with intro-
duced error rates. We implement it on top of a probabilistic
model and probabilistic database management system.2. Background
2.1. Probabilistic databases
Probabilistic databases are database management systems that
facilitate handling of uncertainty in data. In particular, these dat-
abases are designed to perform probabilistic inference on very
large data sets. Typically, these systems implement a ‘‘possible
worlds’’ model, where each possibility is represented by a separate
attribute, tuple, or set of tuples, each tagged with a probability or
conﬁdence level. Consistent with probability theory, the sum of
all possible values must equal one. Query support is usually pro-
vided in the form of enhancements to the basic query language
(usually SQL) for the database [20]. The beneﬁts of probabilistic
databases include the ability to provide the user with not only a
single query answer, but also a stochastic result or level of conﬁ-
dence based on the underlying data. Another use is for imputing
missing data values or extrapolating results stochastically [21].
These databases are applicable to many domains, especially where
there is uncertainty regarding the underlying data. For example, a
common application of probabilistic databases is in data ware-
houses built from heterogeneous sources where multiple values
exist for a single attribute.
Example systems include Trio (http://infolab.stanford.edu/trio/),
from Stanford University [22], the Monte Carlo Database System
(MCDB) which stores distribution parameters instead of actual
probabilities and provides stochastic prediction capabilities [23]
and Cornell University’s MayBMS (http://maybms.source-
forge.net/). Probabilistic databases are an active research area in
Computer Science, and new capabilities continue to be developed.
For example, Kanahal et al. have added sensitivity analysis func-
tionality to a system in order to help the user identify variables that
have high impact on query output [24].
MayBMS extends the PostgreSQL open source database
(http://www.postgresql.org) with probabilistic versions of condi-
tional tables as well as commands to create, manipulate, and inter-
rogate them [25]. MayBMS supports a ‘‘possible worlds’’ model,
where each record in a conditional table is associated with a prob-
ability based on the likelihood of it occurring in one possible world
[26].
Overall, probabilistic databases are a relatively immature tech-
nology, used predominantly in computer science research. To date,
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care. Chung and Hsaio discuss some potential applications of prob-
abilistic databases to the medical ﬁeld, including data
consolidation from disparate sources into a common data
warehouse. They present a straightforward model deriving proba-
bilities from the frequency of values found in the source databases
[27]. In Edelman et al., researchers used probabilistic linkage to
compare and match burn data from ﬁve different databases in or-
der to obtain an overall picture of burn injuries in the state of Utah.
The researchers used specialized software to match data between
sources and return results that had at least 90% conﬁdence in the
match [28]. While this particular application did not use a proba-
bilistic database per se, the researchers used similar techniques
to those supported by probabilistic databases to reduce over
counting of injuries. Probabilistic data and claims databases are
increasingly used to determine patient diagnoses.2.2. Data model
In order to model uncertainty in a probabilistic database, one
must have a probabilistic model and a method for determining
probabilities. Since the focus of this research was the probabilistic
methods, we developed a lightweight model of patient data and
the healthcare delivery process. In particular, our model represents
a common encounter – billing approach and uses probability dis-
tributions to generate simulated patient and visit data.
Other patient and patient care models have been developed.
OMOP provides an open source model of simulated patient data
using ﬁrst order Markov models to determine patient conditions
and medications. Since one of OMOP’s key research goals is to
study adverse drug events, more accurate modeling of conditions
and associated medications is critical to that application [29].
Other efforts aim to model patient physiology and disease pro-
gression in more detail. Such models include Archimedes and Ente-
los. Archimedes focuses on patient physiology and disease
progression [30] and Entelos on disease mechanisms, including pa-
tient characteristics [31]. To the best of our knowledge, no existing
model describes an outpatient episodic care model such as the one
we present here.2.3. Bayes’ theorem
Bayes’ Theorem is a central part of probability theory. It was
communicated to the Royal Society of London in a letter describing
an essay discovered by a Mr. Price among the possessions of Rev-
erend Thomas Bayes after Rev. Bayes’ death [32]. In summary,
Bayes’ Theorem describes the relationship between the probability
of an event before and after acquiring information, also known as a
conditional probability. The probability of an event before gaining
information is called the prior probability. The probability of an
event after gaining information is the posterior probability. A com-
monly accepted form of Bayes’ Theorem is presented in Eq. (1) [33].
PðDjþÞ ¼ pðDÞ  pðþjDÞ
pðDÞ  pðþjDÞ þ pð:DÞ  pðþj:DÞ ð1Þ
We base our probabilistic model on Bayesian models of clinical
test performance. Bayesian models of test performance compute
the conditional probability of a disease being present if a test is po-
sitive or negative. Tests such as lab tests, imaging studies, clinical
diagnosis, and even billing can be evaluated against a gold standard
tomeasureperformance. Test performance ismeasured in sensitivity
and speciﬁcity. Sensitivity is the probability that a known diseased
patient has a positive test. Speciﬁcity is the true negative rate. An-
other commonly used term is the probability that a patient with apositive test will have a disease, the positive predictive value. These
probabilities are valid only in populations where the disease preva-
lence is similar to the one in the gold standard population [34].
Given the prevalence, or prior probability of an event, and the
sensitivity and speciﬁcity for a test, one can use Bayes’ Theorem
to determine the revised, conditional, or posterior probability of
an event. A common form of Bayes’ Theorem using these values
to determine the probability of the disease (D) given the ﬁnding
(F) is shown in Equation (2) [33,34].
PðDjFÞ¼ prevalenesensitivity
prevalencesensitivityþð1prevalenceÞð1specificityÞ
ð2Þ
In this project, we use Bayes’ Theorem to calculate the revised
probability of the presence of a disease given the prior probability
and the new information available, in this case, the presence or ab-
sence of billing data for the disease. Bayesian methods are tradi-
tionally used to impute missing data [35], and our research
follows this approach.
Numerous probabilistic techniques, including Bayes’ Theorem,
have been used to model the accrual of patients in clinical trials,
with varying degrees of success [36]. In general, Bayes’ Theorem
was found to be more reliable as increasing amounts of data were
available to compute further posterior probabilities.3. Methods
To model a typical patient data warehouse, we created a simple
model of healthcare delivery.
As seen in Fig. 1, this model contains patients, who have condi-
tions (represented by ICD Codes) and who visit providers. These
patients are sent for lab tests per predeﬁned Order Sets and are
billed based on provider diagnosis of conditions, which are desig-
nated with ICD codes. Lab tests have predeﬁned ranges that are
used to determine whether a test result is normal or abnormal.
We also track the Patients’ Ground Truth so we know what condi-
tion(s) each patient actually has. The ground truth information is
used only for accuracy determination and for simulating expert
opinion.
The underlying process for generating the simulated data is de-
scribed in Fig. 2.
3.1. Base data
Each step illustrated in Fig. 2 is necessary to generate the syn-
thetic data required by our analysis. Prior to running the data gen-
eration, we populate a number of tables with base data. These
tables include: Races, Providers, ICD Codes, Lab Tests and Units.
This data can be customized based on the desired characteristics
of the synthetic data. For this simulation, we used ﬁve races, 10
providers, eight ICD Codes, 10 units, and 32 lab tests.
3.2. Simulated data generation
We generate one patient at a time. For each patient we assign
an age and race. Next, we assign a number of conditions. This infor-
mation is stored in the Patients Ground Truth table for evaluation
of results. After this step, we assign the patient a primary care pro-
vider and determine the number of visits. For each visit, we decide
if the PCP is available, and assign a different provider, if not.
Most of the process steps described in Fig. 2 are stochastic in
nature. For example, initial demographic information including
race and age are assigned based on random samples from normal
and uniform distributions, respectively. Patient conditions are as-
signed from the list of predeﬁned conditions in the database by
Fig. 1. Entity-relationship diagram.
Fig. 2. Patient generation workﬂow (PCP = Primary Care Provider).
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number is smaller than the condition’s prevalence then a second
random number is generated over the same range. If that second
number is less than the ‘‘probability_treated_here’’ value, then
we ﬂag the condition as being treated ‘‘here’’. Our model is
simplistic in that each condition is independent of others, that is,
having one condition does not make a patient more or less likely
to have any other condition.
The number of visits is sampled froma Pareto distribution,which
is a positively valued, highly left skewed distribution. The data for
number of visits in the UTHealth CDW follow this distribution. For
each visit, there is a chance that the patient’s PCP is unavailable, in
which case an alternate provider is assigned. Since each provider
has a likelihood ofmaking a diagnostic error during a visit, changing
providers has the potential to impact the diagnostic accuracy of a
visit. We then sample a uniform distribution to determine whether
or not the providermisses one of the patient’s conditions or if a new
condition is added to the problem list for a particular visit.
For each visit, labs are generated based on the predeﬁned Order
Sets for each condition the patient has. Extra labs are added atrandom with a predeﬁned probability and corresponding lab val-
ues are assigned.
We generate billing data based on the patient conditions diag-
nosed and ‘‘treated’’ by the provider. No new errors are introduced
into the billing process. Consequently, all billing errors in our mod-
el are due to downstream effects of earlier errors, including pro-
vider misdiagnosis.
One of the unique characteristics of our model is the use of the
‘‘probability treated here’’ value. As previously mentioned,
UTHealth provides clinical services in the greater Houston area.
However, UTHealth is located in the same medical center as the
University of Texas MD Anderson Cancer Center. Consequently,
many of the UTHealth patients with cancer obtain specialty care
at MD Anderson. As a result, we have found that billing records
of whether or not a patient has cancer do not reﬂect clinical reality
as often as desired [4], since we do not typically treat patients for
that condition. As legally required, we do not bill patients for con-
ditions we do not treat. Although this speciﬁc situation is some-
what unique to UTHealth, similar distribution skewing conditions
happen at other clinical institutions.
We generate additional data in the Generate Visits step (Fig. 2),
at which time additional errors may occur, as shown in Fig. 3. We
reviewed the literature and found that error rates vary widely
throughout the care process. For example, Nahm describes single
entry error rates between 4 and 650 per 10,000 data ﬁelds [37].
Diagnostic accuracy also varies. Montnémery reports 76.5% of asth-
ma cases were properly diagnosed during the ﬁrst visit in Sweden
[38] and physician ability to accurately assess the category of rheu-
matoid arthritis activity varied between 31% and 88% depending on
the disease progression class [39]. We conservatively assume that
each provider has a different error rate chosen at random between
0% and 2%. This error rate is the probability that the provider com-
mits an error of either omitting an existing condition or diagnosing
a nonexistent condition on each visit.
Fig. 3. Visit generation workﬂow (simpliﬁed).
Table 2
Patient count approaches.
Approach Number of
records
examined
Source of truth
Actual count All Ground truth
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ence or absence of a condition is constant throughout the simula-
tion. This assumption is made in order to make the analysis more
interesting and relevant by providing an on-going opportunity for
diagnosis or misdiagnosis. It is also realistic, as nearly half of all
Americans are estimated to have one or more chronic condition
by 2004 [40].Count of billing (C-B) All None
Omniscient one shot (O-OS) All Ground truth
Omniscient Bayesian chain (O-CH) All Ground truth
Review one shot (R-OS) Sample Simulated expert review
Review Bayesian chain (R-CH) Sample Simulated expert review3.3. Database speciﬁcs
The patient database generator is written in Python and is
parameterized for: number of patients; distribution of visits per
patient; and availability of provider. The data generator is available
at http://github.com/drh-uth/DataFakehouse.
The database was created in MayBMS version 2.1-beta, which
extends the functionality of the PostgreSQL 8.3.3 database. For this
research, we created a database of 10,000 patients.
The prevalence of each condition, and the rate at which the
institution bills for each condition, are presented in Table 1.3.4. Patient counts
The goal of this research was to evaluate the accuracy of differ-
ent methods of counting patients in a clinical data warehouse. WeTable 1
Prevalence and probability of treatment for the simulated conditions.
Condition Prevalence (%) Probability of being
treated at the simulated institution (%)
1 30 90
2 1 10
3 20 1
4 60 70
5 15 95
6 30 50
7 10 30
8 45 95analyzed six different approaches to computing these patient
counts. These techniques are summarized in Table 2.
We use two straightforward methods for computing patient
counts: Actual Count, which examines the ground truth table and
counts the number of patients with the speciﬁed condition, and
Count of Billing, which returns the number of unique patients with
a condition from the billing table.
For the remaining methods, we treat billing like a diagnostic
test, having both sensitivity and speciﬁcity. We use two methods
of computing sensitivity and speciﬁcity – the ‘‘Omniscient’’ meth-
od, in which we use the ground truth to determine true positive,
false positive, true negative and false negative values and the ‘‘Sim-
ulated Expert Review’’ approach. The latter approach is more real-
istic in that it emulates current practices where a representative
sample of records are reviewed and labeled by experts. The error
rates discovered in the sample are used to extrapolate values for
the rest of the data. We use the ground truth to simulate the
behavior of the expert chart reviewers.
In addition to these two approaches, we use two methods of
computing the posterior probability of a patient having a condi-
tion. One technique is a ‘‘Bayesian Chain’’, where Bayes’ Theorem
is used to calculate the posterior probability of each patient having
each condition. In this technique we compute a revised probability
of the condition after each visit, using the posterior probability of
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subsequent visit. The initial value of the prior probability used in
this approach is the overall prevalence of the condition in the gen-
eral population. Bayes’ Theorem is applied iteratively for each pa-
tient after each billing cycle. The calculations for posterior
probabilities are shown in Eq. (2) and the ‘‘Bayesian Chain’’ equa-
tions are stated in Eq. (3). In the chaining equations, the initial
probability (time = 0) is set to be the condition prevalence. At each
iteration, the next, or ‘‘chained’’, probability (time = t + 1) is based
on the probability at time t and the sensitivity and speciﬁcity of
the condition being billed given the presence or absence of the
condition.
PðDjBillingÞ0¼PrevalenceðDÞ
PðDjBillingÞtþ1¼
PðDjBillingÞtsensitivity
PðDjBillingÞtsensitivityþð1PðDjBillingÞtÞð1specificityÞ
ð3Þ
A second ‘‘One-shot Bayesian’’ approach computes the probabil-
ity of a patient having a condition based on whether or not the pa-
tient is ever billed for the condition. To compute this probability,
we use a single application of Bayes’ Theorem. This approach is
based on Liao’s use of billing codes from electronic medical records
to discover patients with rheumatoid arthritis [8].
In order to compute the posterior probability that a patient has a
condition using Bayes’ Theorem, sensitivity and speciﬁcity values
are required. To compute these values we create a table that con-
tains every condition billed, the associated visit, patient and ICD
code status (absent or present) and populate it with the data from
the model. Four key values are needed to compute these values:
billed (absent or present) and patient condition (absent or present).
These values correspond to True Positive (TP), False Positive (FP),
True Negative (TN) and False Negative (FN), as shown in Table 3.
For the Simulated Review approach we imitate an expert read-
ing through and labeling a small subset of the records in the data
warehouse. We select a random sample of 500 records. For each
of these records, our simulated experts determine the set of condi-
tions a patient has, regardless of billing. We implement the simu-
lated review by sampling records and looking up the patient’s
corresponding entries in the Patients Ground Truth table. True Po-Table 3
Contingency table for billing/condition pairs. TP = true positive, FP = false positive,
TN = true negative and FN = false negative.
Fig. 4. Example MayBMS code to create a probabilistic table. patients contains all patie
that contains all combinations of all existing conditions a patient might have (i.e. disease
stored procedure that computes the frequency of each combination in the database (nositive, False Positive, True Negative, and False Negative are com-
puted by comparing the expert opinion to the recorded billing
data. In other words, the True Positive rate is the percentage of
the 500 sample records that are correctly labeled as the patient
having the condition.
For the Omniscient approaches, we do not use a random sam-
ple. Instead, we examine every single patient in the entire data
warehouse. We thus compare the ground truth to the billed condi-
tions for the entire data warehouse.
The familiar format for a contingency table is shown in Table 3.
Once the contingency tables are populated, sensitivity and spec-
iﬁcity for each condition-billing pair are computed, using the
formulas in Eqs. (4) and (5).Sensitivity ¼ TP
TP þ FN ð4Þ
Specificity ¼ TN
TN þ FP ð5Þ
Finally, we use Bayes’ Theorem (Eq. (3)) to calculate the poster-
ior probability of each patient having each condition.
For each probabilistic method, we create a probabilistic table to
hold possible rows in MayBMS with all possible combinations of
conditions for each patient and their probabilities (computed as
the product of the probabilities of each condition, given their
independence). The table is instantiated using the MayBMS re-
pair key command over the patient ﬁeld (Fig. 4), telling MayBMS
that only one patient and combination of conditions really existed.
An expected count is obtained using the MayBMS ecount () func-
tion. We evaluate the quality of this count by subtracting it from
the actual count, as determined by the ground truth, and normal-
izing it to obtain the error rate for each condition (Eq. (6)). The er-
ror rate is also averaged across all conditions in the database to
obtain an average error rate for each technique.
The repair key patientid MayBMS statement implies that
only one row per patientid exists.Error ¼ absðpredicted count actual countÞ
actual count
ð6Þ
We obtain the predicted counts for each method as follows:
Count of Billing: We add all patients who were billed, at least
once, for each condition (Fig. 5).
Review-one shot: We perform a simulated review of 500 cases,
and compute the sensitivity and speciﬁcity of the billing for each
condition as described. For each patient, we compute the condi-
tional probability of the patient having the condition given that
he or she was billed or not, and obtain the total expected count.
Review-chaining: We use the same simulated review of 500
cases. For each visit, we compute the probability of the patient
having each condition given that he or she was billed (or not) for
the condition in that visit. This probability becomes the prior prob-
ability for the patient’s next visit (Eq. (3)).
Omniscient methods: We perform the same procedure as
above, but review all 10,000 patients in the simulated warehouse.nts in the data warehouse; possible_condition_combinations is a view (not shown)
1; disease 2; disease 1 and disease 2, and so on); probability_per_combination is a
t shown).
Fig. 5. SQL code to count patients billed by condition.
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The results are reported in Table 4 as error rates for all eight
conditions in the simulation for each counting technique when
compared to the ground truth.Table 4
Error rates on patient counts by approach.
Cond. C-B (%) O-CH (%) O-OS (%) R-CH (%) R-OS (%)
1 8.7 7.2 3.6 5.4 0.4
2 89.8 10.6 4.2 100.0 1.8
3 99.0 1.9 0.9 100.0 1.7
4 29.9 12.6 0.3 11.7 1.4
5 1.0 3.4 0.7 1.8 3.6
6 49.4 20.2 1.2 50.6 1.3
7 67.7 28.4 6.5 13.2 5.3
8 4.4 1.6 2.5 3.5 1.3
Avg. error 43.7 10.7 2.5 35.8 2.1
Std. dev. 38.8 9.5 2.2 42.6 1.6
In the above table, Count of Billing is the non-probabilistic count of patients who
were billed for the condition. O-CH = omniscient-chaining, O-OS = omniscient-one
shot, R-CH = review-chaining, and R-OS = review-one shot.5. Discussion
We present two key ﬁndings in this paper: a model for generat-
ing simulated patient data and a probabilistic method for mining
patient data to obtain accurate counts of patients with speciﬁed
conditions.
5.1. Model
Our data model is simple, but very powerful and appropriate to
this application. For example, we assume a normal distribution of
ages across patients. We also treat each condition independently.
While this approach is not representative of reality in most popu-
lations, our focus is on comparison of results from each counting
technique. The techniques we present should work equally well
using a more complex data generation model.
In the end, we did not use all of the different dimensions of our
data model. For example, we did not use race, age or even lab test
information in our analysis. Further, the probabilities assigned to
many of our model parameters, are not based on hard evidence
based research, but were assigned based on clinical experience
and rules of thumb. Our goal in this project was not to perfectly
model clinical care, but to provide a parameterized model that pro-
duces probabilistic data for analysis. Certainly, more parameters
could be added and other values adjusted to better model certain
populations.
Some key strengths of our model are that it is parameterized
and customizable, so the data generated can be easily adjusted to
represent a particular patient population. Another beneﬁt is that
synthetic data, such as produced by our model, is not subject to
privacy rules, allowing researchers to focus on analysis techniques
and enabling them to share their data warehouses easily. Simu-
lated data allows rapid prototyping and research turnaround with-
out the added complexities of accessing actual patient data.
A driving force in this research is whether or not a patient is
billed for a condition. In reality, patients may have chronic condi-
tions that are not recorded in the patient’s record if the condition is
not treated at a facility. A classic example of this is a patient who
has cancer (analogous to a chronic condition for this research)
and is being seen at a tertiary treatment center for care, but is see-
ing a primary care physician for diabetes management. In this case,
the billing code for diabetes would be entered at the primary care
center, but not the cancer condition.
5.2. Model extensions
Our model could be easily extended to meet diverse research
needs. One example is that our model allows us to specify a title
for each provider. The level of title speciﬁed (e.g. RN and MD) could
be used to inﬂuence the diagnoses reached. For example, someconditions might require diagnosis by a higher-level provider. If
that provider is unavailable during a visit, that diagnosis would
not be assigned. Visit dates are also assigned in our model. For this
exercise, we did not rely on any particular frequency or gap be-
tween visits for our analysis. Another logical next step for the mod-
el is to allow conditions to develop and to be cured and to
eliminate the assumption that conditions are independent.
5.3. Methods
The approach we present in this paper has two interesting
dimensions. The ﬁrst is the decision-theoretical approach to
obtaining highly accurate patient counts. We modeled billing as
a test for the presence of a condition and computed its sensitivity
and speciﬁcity. We then applied these measures of the quality of
billing as a test to compute the posterior probability of a patient
actually having a condition. The second is the application of a prob-
abilistic database engine such as MayBMS to clinical data mining.
An important strength of our approach is that the Bayesianmod-
el we present does not require a probabilistic database manage-
ment system. It is possible to implement a similar technique in
any database management system by adding ﬁelds to keep track
of the probability of conditions. MayBMS simply provides a conve-
nient infrastructure to make such computations easy. MayBMS also
has the distinct advantage of being based on a popular database en-
gine, PostgreSQL, which is widely used and well-documented. We
used two key extensions: repair key, which weights the available
record options based on the provided probabilities, and ecount,
which provides the expected count of the values. Once understood,
these extensions are simple to apply to the model.
5.4. Results
Patient counts based on billing data are lower than the counts
produced by the Bayesian approaches. The average error rate for
billing-based counts is 43.7%, while the one-shot techniques have
error rates as low as 2.1%. As Table 4 clearly shows, the variability
of patient counts between conditions was also large, especially for
the less accurate techniques. Conditions that are severely under-
counted when using billing data (for example, condition 3) have
manageable error rates when using one-shot Bayesian approaches.
Conditions that are accurately counted via billing, such as condition
5, may not require the application of Bayesian techniques at all.
An interesting ﬁnding was the poor performance of the ‘‘Bayes-
ian Chain’’ approach. Bayesian chaining has the theoretical advan-
tage of taking into account additional data over time, which has
been shown by Barnard to be a more accurate prediction method
when data continues to present [40]. This is a reasonable approach,
as most organizations have long term billing data for patients.
However, in practice, it is subject to higher error rates. We
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positive bill and a negative bill in the ‘‘one-shot’’ approach. In the
‘‘one-shot’’ approaches we implicitly consider the presence of a
single bill for a condition stronger evidence than any number of
bills without the condition. This preferential treatment of positive
bills is an artifact of the nature of the billing process and regulatory
framework in place in the US healthcare system, as patients are far
more likely to be NOT billed for a condition they DO have than to
be billed for a condition they DO NOT have.
Some limitations of this project are the use of a simulated pa-
tient population, arbitrary error rates, the assumption that all con-
ditions are chronic, and our simple probabilistic model that
assumes conditions are independent of each other. The chronic
condition assumption allows us to evaluate recurring diagnoses
over time. While the model reﬂects some aspects of the clinical
reality of the UTHealth population [4], the behavior of the re-
view-based Bayesian approach on a real patient population is still
unknown. Error rates affect our results quantitatively, i.e. our
numerical results should not be taken as generalizable to any ac-
tual patient population, but this does not affect the validity of
the technique we demonstrate. In the future, we will expand this
research to evaluate Bayesian approaches on more sophisticated
population models and, eventually, real Clinical Data Warehouses.
We acknowledge that our assumption of independence be-
tween conditions may be controversial. However, we believe that
it reﬂects a user query model that we encounter repeatedly in
CDW operation, namely, that researchers preparing a grant appli-
cation or planning a study desire to obtain a count of patients
billed for certain speciﬁc ICD-9-CM codes. In this common sce-
nario, the researcher assumes that the billing data accurately rep-
resents all patients with that condition. This is the situation we
attempt to model; we recognize that a more sophisticated model
that leverages known relationships between conditions may be
more accurate at ﬁnding speciﬁc patients correctly. Our model al-
lows us to quickly correct aggregate patient counts without con-
structing disease-speciﬁc dependency models. Other models,
such as OMOP’s OSIM2, may be more appropriate for tasks such
as discovering drug–condition relationships.
6. Conclusions
Bayesian probabilistic approaches improve patient counts on
simulated patient populations. In particular, the approach we pres-
ent in this paper will improve clinical study feasibility analysis and
planning. The one-shot review approach proved to be accurate and
will be the simplest and cheapest to implement in actual practice.
The patient database generator proved to be a useful tool for
this research. The database structure we designed clearly met the
data generation needs for this project. It allowed us to easily pro-
duce a non-uniform patient database. The synthetic database has
the obvious beneﬁts of not requiring IRB approval or HIPAA com-
pliance. In addition, having the known ground truth for the patient
data allows researchers to trivially validate experimental results.
Finally, total patient counts based on billing data are one of the
many possible applications of our Bayesian framework. The broad-
er problem of compensating for bias in other kinds of patient labels
is susceptible to a similar approach and will be the focus of our fu-
ture research.
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